A detailed history of Beech Hill Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beech Hill Advisors, Inc. holds 19,118 shares of BMY stock, worth $765,867. This represents 0.45% of its overall portfolio holdings.

Number of Shares
19,118
Previous 18,827 1.55%
Holding current value
$765,867
Previous $966,000 7.25%
% of portfolio
0.45%
Previous 0.48%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$47.98 - $54.4 $13,962 - $15,830
291 Added 1.55%
19,118 $1.04 Million
Q4 2023

Jan 10, 2024

SELL
$48.48 - $57.85 $19,392 - $23,140
-400 Reduced 2.08%
18,827 $966,000
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $33,286 - $37,219
-575 Reduced 2.9%
19,227 $1.12 Million
Q2 2023

Jul 10, 2023

SELL
$63.71 - $70.74 $7,135 - $7,922
-112 Reduced 0.56%
19,802 $1.27 Million
Q1 2023

Apr 14, 2023

BUY
$65.71 - $74.53 $42,711 - $48,444
650 Added 3.37%
19,914 $1.38 Million
Q4 2022

Jan 17, 2023

SELL
$68.48 - $81.09 $96,556 - $114,336
-1,410 Reduced 6.82%
19,264 $0
Q3 2022

Oct 12, 2022

BUY
$0.13 - $76.84 $19 - $11,526
150 Added 0.73%
20,674 $1.47 Million
Q2 2022

Jul 11, 2022

SELL
$72.62 - $79.98 $831,862 - $916,170
-11,455 Reduced 35.82%
20,524 $1.58 Million
Q1 2022

Apr 19, 2022

SELL
$61.48 - $73.72 $5.61 Million - $6.72 Million
-91,178 Reduced 74.03%
31,979 $2.34 Million
Q4 2021

Jan 19, 2022

SELL
$53.63 - $62.52 $115,143 - $134,230
-2,147 Reduced 1.71%
123,157 $7.68 Million
Q3 2021

Oct 14, 2021

BUY
$59.17 - $69.31 $8,165 - $9,564
138 Added 0.11%
125,304 $7.41 Million
Q2 2021

Jul 15, 2021

SELL
$61.91 - $67.42 $490,141 - $533,764
-7,917 Reduced 5.95%
125,166 $8.36 Million
Q1 2021

Apr 19, 2021

BUY
$59.34 - $66.74 $829,751 - $933,225
13,983 Added 11.74%
133,083 $8.4 Million
Q4 2020

Jan 22, 2021

SELL
$57.74 - $65.43 $158,785 - $179,932
-2,750 Reduced 2.26%
119,100 $7.39 Million
Q3 2020

Oct 19, 2020

SELL
$57.43 - $63.64 $93,323 - $103,415
-1,625 Reduced 1.32%
121,850 $7.35 Million
Q2 2020

Jul 17, 2020

BUY
$54.82 - $64.09 $83,600 - $97,737
1,525 Added 1.25%
123,475 $7.26 Million
Q1 2020

May 05, 2020

SELL
$46.4 - $67.43 $76,560 - $111,259
-1,650 Reduced 1.33%
121,950 $6.8 Million
Q4 2019

Jan 17, 2020

SELL
$49.21 - $64.19 $60,282 - $78,632
-1,225 Reduced 0.98%
123,600 $7.93 Million
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $80,193 - $95,081
-1,875 Reduced 1.48%
124,825 $6.33 Million
Q2 2019

Jul 15, 2019

BUY
$44.62 - $49.34 $580,060 - $641,420
13,000 Added 11.43%
126,700 $5.75 Million
Q1 2019

Apr 09, 2019

BUY
$45.12 - $53.8 $418,488 - $498,995
9,275 Added 8.88%
113,700 $5.43 Million
Q4 2018

Jan 14, 2019

SELL
$48.76 - $63.23 $52,417 - $67,972
-1,075 Reduced 1.02%
104,425 $5.43 Million
Q3 2018

Oct 10, 2018

BUY
$55.19 - $62.25 $46,911 - $52,912
850 Added 0.81%
105,500 $6.55 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $70,742 - $88,172
-1,400 Reduced 1.32%
104,650 $5.79 Million
Q1 2018

Apr 23, 2018

SELL
$59.92 - $68.98 $218,708 - $251,777
-3,650 Reduced 3.33%
106,050 $6.71 Million
Q4 2017

Jan 23, 2018

BUY
$59.94 - $65.35 $2,997 - $3,267
50 Added 0.05%
109,700 $6.72 Million
Q3 2017

Oct 20, 2017

BUY
$55.23 - $63.74 $6.06 Million - $6.99 Million
109,650
109,650 $6.99 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85.2B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Beech Hill Advisors, Inc. Portfolio

Follow Beech Hill Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beech Hill Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beech Hill Advisors, Inc. with notifications on news.